August 21, 2026 Sky Harbour Announces Increase to Recent Registered Direct Common Stock Placement, Updates Investor Conference Calendar, and Announces Filing of Construction Reports
August 21, 2026 Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World’s First Approved 4-1BB-Targeting Therapy
August 21, 2026 Influential Women Spotlights Dr. Lakysha Laing: Advancing Human-Centered Leadership And Customer Experience Innovation